PMA based on overwhelmingly positive results from the pivotal C-GUARDIANS clinical study that were first presented at LINC ...

InspireMD NSPR recently announced that it has submitted a Premarket Approval (PMA) application to the FDA seeking marketing ...

Although there is merit to using DOACs in many common conditions, the manuscript provides a robust summary of clinical trials indicating that DOACs fare worse in patients with mechanical heart valves, ...

InspireMD, Inc., developer of the CGuard embolic prevention stent system for the prevention of stroke, announced that it has ...

Neurointerventional Devices Market is likely to reach US$ 4.1 billion by 2033. The market is further expected to surge at a ...

Global Interventional Neurology Devices Market is valued approximately USD 2.6 billion in 2023 and is anticipated to grow with a growth rate of more than 4.70% over the forecast period 2024-2032. Read ...

Google won a court challenge on Wednesday against a 1.49 billion euro European Union antitrust fine imposed five years ago ...

Thromboembolic events are common complications of nephrotic syndrome.High risk nephrotic syndrome patients with relatively ...

Patients with intermediate-stage liver cancer may benefit from receiving a Lenvima-Keytruda combination with transarterial ...

According to US secondary stroke prevention guidelines, patients with ESUS should not be treated with anticoagulants or ...

Shunnar, M. , Alshaikh, O. , Alzubaidi, M. and Choi, H. (2024) Spontaneous Coronary Artery Disease in a Healthy Fibromuscular Dysplasia Patient: A Case Report. Case Reports in Clinical Medicine, 13, ...